RC(300596)2025-04-21 13:20Dividend and Financial Performance - The company plans to distribute a cash dividend of 3.70 RMB per 10 shares to all shareholders, based on a total of 229,619,667 shares[5]. - The company's operating revenue for 2024 reached ¥5,686,916,460.39, an increase of 7.74% compared to ¥5,278,456,143.60 in 2023[23]. - Net profit attributable to shareholders for 2024 was ¥426,320,047.33, reflecting a growth of 17.61% from ¥362,486,514.16 in 2023[23]. - The net profit after deducting non-recurring gains and losses for 2024 was ¥411,263,644.82, a 19.67% increase from ¥343,666,377.88 in 2023[23]. - The basic earnings per share for 2024 was ¥1.8566, up 17.61% from ¥1.5786 in 2023[23]. - The total assets of the company at the end of 2024 amounted to ¥9,134,140,669.49, marking an 11.21% increase from ¥8,213,505,102.08 at the end of 2023[23]. - The weighted average return on equity for 2024 was 9.95%, up from 9.15% in 2023[23]. - The company reported a total of ¥15,056,402.51 in non-recurring gains for 2024, compared to ¥18,820,136.28 in 2023[29]. Strategic Development and Market Position - The report includes a comprehensive analysis of the company's future development outlook and strategic plans[5]. - The company is actively exploring opportunities for mergers and acquisitions to strengthen its market position[16]. - The company has strategically acquired Jinzhou Kangtai to expand its lubricating oil additives business, enhancing its product offerings in this sector[45]. - The company aims to develop green, environmentally friendly, and composite new products to meet market demands, leveraging policy support and market opportunities[42]. - The company is focused on expanding its international market share while consolidating its leading position in the domestic anti-aging product market[158]. - The company is committed to expanding its market presence through strategic partnerships and acquisitions[140]. Research and Development - The company is focused on research and development of new materials and technologies to enhance product offerings[17]. - The company has established a life sciences division focusing on bioblocks and synthetic biology, investing in two biopharmaceutical companies, Aoruife and Aolife, to create a complete product layout in bioblocks[53][54]. - The company has developed innovative production processes for antioxidants, including RIANOXMD-1024 and RIANOX1010, with multiple patents filed (ZL200810053501.0, ZL201010514830.8)[75]. - The company aims to become a global leader in the antioxidant industry by 2028, with a commitment to maintain an innovation budget of over 4% of revenue[75]. - The company is committed to continuous innovation in its product lines, including multifunctional antioxidants and light stabilizers[76]. - The company has developed a comprehensive range of anti-aging products, including antioxidants and light stabilizers, to enhance the durability of polymer materials[41]. Environmental and Social Responsibility - The company is committed to environmental and social responsibility as part of its corporate governance strategy[18]. - The company has initiated projects focused on EHS data construction and green factory development from 2022 to 2024, aligning with national carbon neutrality policies[106]. - The company emphasizes the "EHS dual essence" concept and has created an internal certification system based on national laws and standards to ensure compliance[167]. Operational Efficiency and Supply Chain Management - The management has highlighted the significance of maintaining a robust supply chain to support market expansion efforts[16]. - The company has integrated supply chain resources globally, with subsidiaries in regions including Germany, the USA, Japan, and Dubai, enhancing its operational efficiency and risk management[88]. - The company is focused on optimizing raw material procurement and energy consumption to maximize cost efficiency[157]. Financial Management and Investment - The company has maintained a strong financial position with no significant liabilities reported in the latest financial statements[139]. - The company has emphasized the importance of self-owned funds in its investment strategy, particularly in relation to its stake in Yixing Chuangju[140]. - The company reported a total investment of ¥675,936,329.92 during the reporting period, a 12.77% increase compared to ¥599,378,833.03 in the previous year[136]. Risk Management - The company faces risks from international policy changes, including trade tensions and currency fluctuations, and is implementing measures to mitigate these risks[161]. - The company has established a robust environmental and safety management system to mitigate risks associated with environmental compliance and safety incidents[166]. - The company is committed to conducting annual impairment tests for acquired assets to identify and address risks promptly[165]. Corporate Governance and Investor Relations - The company has maintained compliance with legal and regulatory requirements in its governance structure, ensuring independent operations from its controlling shareholder[179]. - The company has established a market value management system to enhance investment value and protect stakeholders' rights, approved by the board on February 24, 2025[174]. - The company has actively engaged with investors through online platforms to discuss operational performance and future strategies[170].